Literature DB >> 35110892

CD 34 Staining to the Rescue in an Incidental Capillary Hemangioma of the Bone Marrow.

Saniya Sharma1, Richa Jain2, Jasmina Ahluwalia1.   

Abstract

Intraosseous hemangiomas are extremely rare and benign neoplasms of vascular origin, usually occurring in adults and involving skull bones, vertebra, ribs, sternum, long bones, patella and clavicle. Iliac or pelvic bone involvement is extremely rare. Hemangiomas of the marrow spaces are extremely uncommon. We report this rare neoplasm in a child that was incidentally detected on bone marrow examination for thrombocytopenia which mimicked a metastatic deposit. However, immunostaining with CD34 was successful in characterizing this solid vascular lesion as capillary hemangioma. This report emphasizes the importance of correctly identifying this lesion with the help of simple CD34 immunostaining since no specific therapy is required. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Bone marrow; CD34; Capillary hemangioma

Year:  2021        PMID: 35110892      PMCID: PMC8763995          DOI: 10.1007/s13193-021-01317-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  4 in total

Review 1.  Update on hemangiomas and vascular malformations.

Authors:  J Powell
Journal:  Curr Opin Pediatr       Date:  1999-10       Impact factor: 2.856

2.  Intraosseous haemangioma of the ilium.

Authors:  Josep Puig; Pilar Garcia-Pena; Goya Enriquez; Pere Huguet; Javier Lucaya
Journal:  Pediatr Radiol       Date:  2005-10-25

Review 3.  Hemangioma from head to toe: MR imaging with pathologic correlation.

Authors:  Joan C Vilanova; Joaquim Barceló; James G Smirniotopoulos; Ricard Pérez-Andrés; Miguel Villalón; Josefina Miró; Ferran Martin; Jaume Capellades; Pablo R Ros
Journal:  Radiographics       Date:  2004 Mar-Apr       Impact factor: 5.333

4.  Hemangioma of the Ilium Simulating an Aggressive Bone Lesion on Imaging.

Authors:  Ba D Nguyen
Journal:  Radiol Case Rep       Date:  2015-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.